University of the Sciences President Dr. Helen-Giles Gee, as well as students and faculty from USciences, joined hundreds of life sciences leaders and innovators during the Life Sciences Future Conference on Oct. 13-14 in Philadelphia.
Life Sciences Future was a two-day event designed by Pennsylvania Bio to reflect the rapidly-evolving landscape in healthcare - which includes biopharma, medical device and diagnostics, healthcare IT, contract research organizations, medical research institutions, and the investment community.
The first day of the event kicked off with Life Sciences Future Symposium: Partnerships in Science, which was designed for an exclusive audience of academic researchers, such as USciences students and faculty, to explore best practices for engaging business development representatives at large companies as well as the next steps in developing their technologies. The second day of the conference was jam-packed with speakers, topics and features all related to advancing science and healthcare industries.
Dr. Giles-Gee and students had the opportunity to meet and speak with Michael Sofia, inventor of Sofosbuvir – known by the brand name Sovaldi, a hepatitis C therapy drug approved by the FDA last December.
“The sessions were outstanding and much appreciated by the faculty and students who attended," Dr. Giles-Gee.